Further your education by joining faculty leaders and your peers in the Journal Club Webinar series, reviewing case vignettes or learning more about scholarship opportunities. These webinars are made possible through an educational partnership with ASTRO and the Radiation Oncology Institute (ROI) Juan A. del Regato Fund.
On Tuesday, May 9, 2017, at 5:00 p.m. Eastern time, the May ASTRO-ARRO Journal Club webinar, presented by Dr. Howard Sandler will focus on prostate cancer. RTOG 9601 is a randomized, phase III trial evaluating the role of antiandrogens in
the radiotherapeutic management of salvage therapy following radical prostatectomy. Patients were randomized to placebo or bicalutamide 150 mg daily for 2 years. All patients received salvage RT. PSA at study entry was between 0.2 ng/mL and 4.0 ng/mL. When presented at ASTRO 2015 during the plenary session, an overall survival advantage was noted for patients randomized to bicalutamide Register now for this free webinar!
2016 ASTRO-ARRO Journal Club Webinar Series
2013 ASTRO-ARRO Journal Club Webinar Series
2012 ASTRO-ARRO Journal Club Webinar Series